Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

472 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CCL21 is associated with fatal outcomes in chronic heart failure: data from CORONA and GISSI-HF trials.
Ueland T, Nymo SH, Latini R, McMurray JJ, Kjekshus J, Yndestad A, Fucili A, Grosu A, Masson S, Maggioni AP, Gullestad L, Aukrust P; Investigators of the Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA) trial; Investigators of the GISSI-Heart Failure (GISSI-HF) trial. Ueland T, et al. Among authors: masson s. Eur J Heart Fail. 2013 Jul;15(7):747-55. doi: 10.1093/eurjhf/hft031. Epub 2013 Mar 13. Eur J Heart Fail. 2013. PMID: 23487539 Free article. Clinical Trial.
The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial.
Masson S, Latini R, Carbonieri E, Moretti L, Rossi MG, Ciricugno S, Milani V, Marchioli R, Struck J, Bergmann A, Maggioni AP, Tognoni G, Tavazzi L; GISSI-HF Investigators. Masson S, et al. Eur J Heart Fail. 2010 Apr;12(4):338-47. doi: 10.1093/eurjhf/hfp206. Epub 2010 Jan 22. Eur J Heart Fail. 2010. PMID: 20097683 Free article. Clinical Trial.
Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial.
Røysland R, Masson S, Omland T, Milani V, Bjerre M, Flyvbjerg A, Di Tano G, Misuraca G, Maggioni AP, Tognoni G, Tavazzi L, Latini R; GISSI-HF Investigators. Røysland R, et al. Among authors: masson s. Am Heart J. 2010 Aug;160(2):286-93. doi: 10.1016/j.ahj.2010.05.015. Am Heart J. 2010. PMID: 20691834 Clinical Trial.
Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial.
Ghio S, Scelsi L, Latini R, Masson S, Eleuteri E, Palvarini M, Vriz O, Pasotti M, Gorini M, Marchioli R, Maggioni A, Tavazzi L; GISSI-HF investigators. Ghio S, et al. Among authors: masson s. Eur J Heart Fail. 2010 Dec;12(12):1345-53. doi: 10.1093/eurjhf/hfq172. Epub 2010 Oct 16. Eur J Heart Fail. 2010. PMID: 20952767 Free article. Clinical Trial.
Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials.
Latini R, Gullestad L, Masson S, Nymo SH, Ueland T, Cuccovillo I, Vårdal M, Bottazzi B, Mantovani A, Lucci D, Masuda N, Sudo Y, Wikstrand J, Tognoni G, Aukrust P, Tavazzi L; Investigators of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) and GISSI-Heart Failure (GISSI-HF) trials. Latini R, et al. Among authors: masson s. Eur J Heart Fail. 2012 Sep;14(9):992-9. doi: 10.1093/eurjhf/hfs092. Epub 2012 Jun 27. Eur J Heart Fail. 2012. PMID: 22740508 Free article. Clinical Trial.
n-3 polyunsaturated fatty acids and atrial fibrillation in patients with chronic heart failure: the GISSI-HF trial.
Aleksova A, Masson S, Maggioni AP, Lucci D, Fabbri G, Beretta L, Mos L, Paino AM, Nicolosi GL, Marchioli R, Tognoni G, Tavazzi L, Sinagra G, Latini R; GISSI-Heart Failure Investigators. Aleksova A, et al. Among authors: masson s. Eur J Heart Fail. 2013 Nov;15(11):1289-95. doi: 10.1093/eurjhf/hft103. Epub 2013 Jul 9. Eur J Heart Fail. 2013. PMID: 23839902 Free article. Clinical Trial.
Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes.
Cosmi F, Shen L, Magnoli M, Abraham WT, Anand IS, Cleland JG, Cohn JN, Cosmi D, De Berardis G, Dickstein K, Franzosi MG, Gullestad L, Jhund PS, Kjekshus J, Køber L, Lepore V, Lucisano G, Maggioni AP, Masson S, McMurray JJV, Nicolucci A, Petrarolo V, Robusto F, Staszewsky L, Tavazzi L, Teli R, Tognoni G, Wikstrand J, Latini R. Cosmi F, et al. Among authors: masson s. Eur J Heart Fail. 2018 May;20(5):888-895. doi: 10.1002/ejhf.1146. Epub 2018 Feb 28. Eur J Heart Fail. 2018. PMID: 29488676 Free article. Clinical Trial.
Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results.
Boccanelli A, Mureddu GF, Cacciatore G, Clemenza F, Di Lenarda A, Gavazzi A, Porcu M, Latini R, Lucci D, Maggioni AP, Masson S, Vanasia M, de Simone G; AREA IN-CHF Investigators. Boccanelli A, et al. Among authors: masson s. Eur J Heart Fail. 2009 Jan;11(1):68-76. doi: 10.1093/eurjhf/hfn015. Eur J Heart Fail. 2009. PMID: 19147459 Free article. Clinical Trial.
472 results